39 research outputs found
Growth and development of children on Aruba in 1974
Aruba: a handful of stones, white sand, cacti and
divi-divi trees, scorching in the tropical sun,
washed by a sea possessing every possible shade of
blue. An island that is nowhere longer than thirty
kilometres and nowhere wider than eight kilometres,
situated off the Venezuelan coast, whose Paraguana
peninsula can even be seen from Aruba in fair weather
Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes
Site-specific deletions in the tal-1 gene are reported to occur in 12-26% of T cell acute lymphoblastic leukemias (T-ALL). So far two main types of tal-1 deletions have been described. Upon analysis of 134 T-ALL we have found two new types of tal-1 deletions. These four types of deletions juxtapose the 5' part of the tal-1 gene to the sil gene promoter, thereby deleting all coding sil exons but leaving the coding tal-1 exons undamaged. The recombination signal sequences (RSS) and fusion regions of the tal-1 deletion breakpoints strongly resemble the RSS and junctional regions of immunoglobulin/T cell receptor (TCR) gene rearrangements, which implies that they are probably caused by the same V(D)J recombinase complex. Analysis of the 134 T-ALL suggested that the occurrence of tal-1 deletions is associated with the CD3 phenotype, because no tal-1 deletions were found in 25 TCR-gamma/delta + T-ALL, whereas 8 of the 69 CD3- T-ALL and 11 of the 40 TCR-alpha/beta + T-ALL contained such a deletion. Careful examination of all TCR genes revealed that tal-1 deletions exclusively occurred in CD3- or CD3+ T-ALL of the alpha/beta lineage with a frequency of 18% in T-ALL with one deleted TCR-delta allele, and a frequency of 34% in T-ALL with TCR-delta gene deletions on both alleles. Therefore, we conclude that alpha/beta lineage commitment of the T-ALL and especially the extent of TCR-delta gene deletions determines the chance of a tal-1 deletion. This suggests that tal-1 deletions are mediated via the same deletion mechanism as TCR-delta gene deletions
Comparative analysis of Ig and TCR gene rearrangements at diagnosis and at elapse of childhood precursor-B–ALL provides improved strategies for selection of stable PCR targets for monitoring of minimal residual disease
Immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements are excellent patient-specific polymerase chain reaction (PCR) targets for detection of minimal residual disease (MRD) in acute lymphoblastic leukemia (ALL), but they might be unstable during the disease course.
Therefore, we performed detailed molecula
Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: Implications for monitoring of minimal residual disease
We studied 57 childhood acute lymphoblastic leukaemia (ALL) patients who remained in continuous complete remission after treatment according to the Dutch Childhood Leukaemia Study Group ALL-8 protocols. The patients were monitored at 18 time points during and after treatment [640 bone marrow (BM) and 600 blood samples] by use of cytomorphology and immunophenotyping for the expression of TdT, CD34, CD10 and CD19. Additionally, 60 BM follow-up samples from six patients were subjected to clonality assessment via heteroduplex polymerase chain reaction (PCR) analysis of immunoglobulin VH-JH gene rearrangements. We observed substantial expansions of normal precursor B cells in regenerating BM not only after maintenance therapy but also during treatment. At the end of the 2-week intervals after consolidation and reinduction treatment, B-cell-lineage regeneration was observed in BM with a large fraction of immature CD34+/TdT+ B cells. In contrast, in regenerating BM after cessation of maintenance treatment, the more mature CD19+/CD10+ B cells were significantly increased, but the fraction of immature CD34+/TdT+ B cells
Fusion of the homeobox gene HLXB9 and the ETV6 gene in infant acute myeloid leukemias with the t(7;12)(q36;p13)
Recently, we and others reported a recurrent t(7;12)(q36;p13) found in
myeloid malignancies in children < or =18 months of age and associated
with a poor prognosis. Fluorescence in situ hybridization studies mapped
the 12p13 breakpoint to the first intron of ETV6 and narrowed down the
region of 7q36 involved. By using the sequences made public recently by
the Human Genome Project, two candidate genes in 7q36 were identified: the
homeobox gene HLXB9 and c7orf3, a gene with unknown function. Reverse
transcription-PCR of two cases with t(7;12), using primers for c7orf3 and
ETV6, was negative. However, reverse transcription-PCR for HLXB9-ETV6
demonstrated alternative splicing; the two major bands corresponded to
fusion of exon 1 of HLXB9 to exons 2 and 3, respectively, of ETV6. The
reciprocal ETV6-HLXB9 transcript was not detected. It remains to be
elucidated if the leukemic phenotype is attributable to the formation of
the HLXB9-ETV6 fusion protein, which includes the helix-loop-helix and E26
transformation-specific DNA binding domains of ETV6 or to the disruption
of the normal ETV6 protein
Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia
Resistance to L-asparaginase in leukemic cells may be caused by an
elevated cellular expression of asparagine synthetase (AS). Previously, we
reported that high AS expression did not correlate to L-asparaginase
resistance in TEL-AML1-positive B-lineage acute lymphoblastic leukemia
(ALL). In the present study we confirmed this finding in TEL-AML1-positive
patients (n = 28) using microarrays. In contrast, 35
L-asparaginase-resistant TEL-AML1-negative B-lineage ALL patients had a
significant 3.5-fold higher AS expression than 43 sensitive patients (P <
.001). Using real-time quantitative polymerase chain reaction (RTQ-PCR),
this finding was confirmed in an independent group of 39 TEL-AML1-negative
B-lineage ALL patients (P = .03). High expression of AS was associated
with poor prognosis (4-year probability of disease-free survival [pDFS]
58% +/- 11%) compared with low expression (4-year pDFS 83% +/- 7%; P =
.009). We conclude that resistance to l-asparaginase and relapse risk are
associated with high expression of AS in TEL-AML1-negative but not
TEL-AML1-positive B-lineage ALL
Het alveolaire rabdomyosarcoom met leukemische presentatie
Contains fulltext :
23992___.PDF (publisher's version ) (Open Access
Comparison of the antileukemic activity in vitro of dexamethasone and prednisolone in childhood acute lymphoblastic leukemia
Contains fulltext :
23560___.PDF (publisher's version ) (Open Access
High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia: results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.
Contains fulltext :
24010___.PDF (publisher's version ) (Open Access